Skip to main content
. 2013 Jun 20;8(6):e65762. doi: 10.1371/journal.pone.0065762

Figure 1. Rapid progression of IM-resistant tumor after SU treatment.

Figure 1

A patient harboring KIT exon 11Val555_Leu576del/17Asn822Lys mutated, metastatic GIST within the liver after 3 months of SU at dose of 50 mg/day, 4 weeks-on/2 weeks-off., (a) before and (n) after SU treatment.